These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28624498)

  • 1. Impact of glycemic variability on the occurrence of periprocedural myocardial infarction and major adverse cardiovascular events (MACE) after coronary intervention in patients with stable angina pectoris at 6months follow-up.
    Xia J; Xu J; Hu S; Hao H; Yin C; Xu D
    Clin Chim Acta; 2017 Aug; 471():196-200. PubMed ID: 28624498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical outcomes according to presentation of angina pectoris versus acute myocardial infarction in patients who underwent a percutaneous coronary intervention with a drug-eluting stent.
    Seo SM; Kim TH; Koh YS; Her SH; Shin DI; Park HJ; Kim PJ; Park CS; Lee JM; Kim DB; Kim HY; Chang K; Yoo KD; Jeon DS; Chung WS; Seung KB;
    Coron Artery Dis; 2016 Mar; 27(2):143-50. PubMed ID: 26693807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials.
    Wang L; Peng P; Zhang O; Xu X; Yang S; Zhao Y; Zhou Y
    PLoS One; 2014; 9(12):e113352. PubMed ID: 25473831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Strut Width in Periprocedural Myocardial Infarction: A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent.
    Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Naganuma T; Sticchi A; Figini F; Latib A; Chieffo A; Carlino M; Montorfano M; Colombo A
    JACC Cardiovasc Interv; 2015 Jun; 8(7):900-9. PubMed ID: 26003020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of periprocedural biomarker elevation on mortality in stable angina pectoris patients undergoing elective coronary intervention: a systematic review and meta-analysis including 24 666 patients.
    Soud M; Hideo-Kajita A; Ho G; Yacob O; Alahdab F; King F; Waksman R; McFadden EP; Garcia-Garcia HM
    Coron Artery Dis; 2020 Mar; 31(2):137-146. PubMed ID: 31609755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact on prognosis of periprocedural myocardial infarction after percutaneous coronary intervention.
    Gili S; D'Ascenzo F; Moretti C; Omedè P; Vilardi I; Bertaina M; Biondi Zoccai G; Sheiban I; Stone GW; Gaita F
    J Interv Cardiol; 2014 Oct; 27(5):482-90. PubMed ID: 25175019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization.
    Nusca A; Patti G; Marino F; Mangiacapra F; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):377-84. PubMed ID: 21681905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-O blood groups can be a prognostic marker of in-hospital and long-term major adverse cardiovascular events in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Cetin MS; Ozcan Cetin EH; Aras D; Topaloglu S; Temizhan A; Kisacik HL; Aydogdu S
    Thromb Res; 2015 Sep; 136(3):599-605. PubMed ID: 26251078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvage.
    Marfella R; Rizzo MR; Siniscalchi M; Paolisso P; Barbieri M; Sardu C; Savinelli A; Angelico N; Del Gaudio S; Esposito N; Rambaldi PF; D'Onofrio N; Mansi L; Mauro C; Paolisso G; Balestrieri ML
    Int J Cardiol; 2013 Oct; 168(4):3954-62. PubMed ID: 23876463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
    Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
    BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: contributing factors and long-term prognostic impact].
    Han YL; Deng J; Jing QM; Wang SL; Ma YY; Luan B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):483-6. PubMed ID: 16842659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial.
    Antonsen L; Thayssen P; Hansen HS; Maeng M; Tilsted HH; Bøtker HE; Ravkilde J; Madsen M; Sørensen HT; Thuesen L; Lassen JF; Jensen LO
    EuroIntervention; 2014 Jun; 10(2):212-23. PubMed ID: 23838425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between glycemic variability and major adverse cardiovascular and cerebrovascular events (MACCE) in patients with acute coronary syndrome during 30-day follow-up.
    Xia J; Xu J; Li B; Liu Z; Hao H; Yin C; Xu D
    Clin Chim Acta; 2017 Mar; 466():162-166. PubMed ID: 28111271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four-year clinical outcome in asymptomatic patients undergoing coronary computed tomography angiography.
    Zhang KY; Gai LY; Gai JJ; He B; Guan ZW
    Chin Med J (Engl); 2013; 126(9):1630-5. PubMed ID: 23652041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
    Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
    Sardella G; Conti G; Donahue M; Mancone M; Canali E; De Carlo C; Di Roma A; Calcagno S; Lucisano L; Fedele F
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E36-43. PubMed ID: 22517610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.
    Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M;
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
    Giustino G; Baber U; Stefanini GG; Aquino M; Stone GW; Sartori S; Steg PG; Wijns W; Smits PC; Jeger RV; Leon MB; Windecker S; Serruys PW; Morice MC; Camenzind E; Weisz G; Kandzari D; Dangas GD; Mastoris I; Von Birgelen C; Galatius S; Kimura T; Mikhail G; Itchhaporia D; Mehta L; Ortega R; Kim HS; Valgimigli M; Kastrati A; Chieffo A; Mehran R
    Am J Cardiol; 2015 Sep; 116(6):845-52. PubMed ID: 26174605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.